A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout

NCT05256810 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped The Sponsor elected not to continue with the study

Conditions

Gout

Interventions

DRUG: ALN-XDH
DRUG: Placebo

Sponsor

Alnylam Pharmaceuticals